Neuronetics, Inc. Common Stock (STIM) is a publicly traded Healthcare sector company. As of November 1, 2026, STIM trades at $2.28 with a market cap of $171.44M and a P/E ratio of -1.60. STIM moved -5.46% today. Year to date, STIM is +56.25%; over the trailing twelve months it is -16.67%. Its 52-week range spans $0.80 to $5.34. Analyst consensus is buy with an average price target of $5.50. Rallies surfaces STIM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for STIM, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $2.28 |
| Market Cap | $171.44M |
| P/E Ratio | -1.60 |
| EPS | $-1.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.34 |
| 52-Week Low | $0.80 |
| Volume | 1.05M |
| Avg Volume | 0 |
| Revenue (TTM) | $74.89M |
| Net Income | $-43.73M |
| Gross Margin | 72.32% |
2 analysts cover STIM: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.50.